We are live on
!
Find out more
ACM
Alethea Capital Management Portfolio holdings
AUM
$241M
1-Year Est. Return
112.74%
This Fund
S&P 500
This Quarter
Est. Return
+26.26%
1 Year Est. Return
+112.74%
3 Year Est. Return
+274.73%
5 Year Est. Return
+347.03%
10 Year Est. Return
+2,691.05%
AUM
$171M
AUM Growth
+$16.6M
(+11%)
Cap. Flow
-$14.3M
Cap. Flow
% of AUM
-8.35%
Top 10 Holdings %
Top 10 Hldgs %
79.62%
Holding
111
New
34
Increased
12
Reduced
20
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPPI
Spectrum Pharmaceuticals Inc
SPPI
|
+$1.31M |
| 2 |
Axsome Therapeutics
AXSM
|
+$1.29M |
| 3 |
Coca-Cola
KO
|
+$768K |
| 4 |
Target
TGT
|
+$618K |
| 5 |
Quest Diagnostics
DGX
|
+$602K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$17.1M |
| 2 |
Capital One
COF
|
+$1.65M |
| 3 |
Kura Oncology
KURA
|
+$1.48M |
| 4 |
Mid-America Apartment Communities
MAA
|
+$973K |
| 5 |
VMRK
Vivmark Residential
VMRK
|
+$849K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 58.68% |
| 2 | Miscellaneous | 20.68% |
| 3 | Consumer Staples | 3.95% |
| 4 | Utilities | 3.92% |
| 5 | Financials | 3.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Axsome Therapeutics
AXSM
$10.9B
| $83M | 48.53% |
1,008,508
+16,754
| +2% | +$1.29M |
|
|
2
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.5B
| $32.3M | 18.87% |
352,478
-186,695
| -35% | -$17.1M |
|
|
SPPI
3
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $3.83M | 2.24% |
1,134,271
+450,082
| +66% | +$1.31M |
|
|
CDTX
4
DELISTED
Cidara Therapeutics
CDTX
| $3.79M | 2.22% |
51,419
+6,676
| +15% | +$433K |
|
|
5
Capital One
COF
$131B
| $3.62M | 2.12% |
57,837
-26,569
| -31% | -$1.65M |
|
|
6
Kura Oncology
KURA
$1.11B
| $3.52M | 2.06% |
216,171
-102,821
| -32% | -$1.48M |
|
7
iShares 0-1 Year Treasury Bond ETF
SHV
$20.9B
| $2.27M | 1.33% |
20,534
| – | – |
|
8
Bristol-Myers Squibb
BMY
$132B
| $1.52M | 0.89% |
25,793
+4,571
| +22% | +$273K |
|
9
Eversource Energy
ES
$26.9B
| $1.21M | 0.71% |
14,484
-728
| -5% | -$60.3K |
|
10
Kimberly-Clark
KMB
$34.2B
| $1.14M | 0.67% |
8,052
+3,552
| +79% | +$490K |
|
11
Waste Management
WM
$87B
| $998K | 0.58% |
9,424
+4,924
| +109% | +$497K |
|
12
Brookfield Infrastructure Partners
BIP
$17.1B
| $982K | 0.57% |
35,826
-944
| -3% | -$25.2K |
|
13
Procter & Gamble
PG
$338B
| $962K | 0.56% |
8,049
+3,899
| +94% | +$455K |
|
14
CMS Energy
CMS
$21.6B
| $945K | 0.55% |
16,178
+7,404
| +84% | +$429K |
|
15
AbbVie
ABBV
$440B
| $914K | 0.53% |
9,311
-429
| -4% | -$37.8K |
|
|
AVB
16
DELISTED
AvalonBay Communities
AVB
| $887K | 0.52% |
5,736
-2,427
| -30% | -$384K |
|
17
Entergy
ETR
$51.9B
| $884K | 0.52% |
18,852
-2,404
| -11% | -$117K |
|
|
18
Coca-Cola
KO
$380B
| $745K | 0.44% |
+16,668
| New | +$768K |
|
19
Phillips 66
PSX
$103B
| $700K | 0.41% |
9,734
-4,800
| -33% | -$340K |
|
20
Merck
MRK
$366B
| $688K | 0.4% |
9,325
+6,181
| +197% | +$465K |
|
|
21
Target
TGT
$73.9B
| $650K | 0.38% |
+5,416
| New | +$618K |
|
|
22
Quest Diagnostics
DGX
$26B
| $647K | 0.38% |
+5,677
| New | +$602K |
|
23
3M
MMM
$86.4B
| $625K | 0.37% |
4,789
+125
| +3% | +$15.8K |
|
24
Apple
AAPL
$4.61T
| $620K | 0.36% |
6,800
| – | – |
|
25
Microsoft
MSFT
$3.67T
| $611K | 0.36% |
3,000
| – | – |
|
Similar funds
NIA
PPW
CWWM
PFA
TP
RA
FA
ACP
Alethea Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Alethea Capital Management held 111 positions worth $171M, up 11% from $154M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Alethea Capital Management withdrew a net $14.3M in Q2 2020, closing 26 positions and reducing 20 holdings. Its most notable exit was Vivmark Residential, an estimated $849K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 59% of assets, up from 45% a quarter earlier, followed by Miscellaneous and Consumer Staples.
Against the trend, Alethea Capital Management opened a new position in Coca-Cola worth $745K.
- Alethea Capital Management's largest Q2 2020 buy was Coca-Cola: 16,668 shares worth $745K.
- Alethea Capital Management added most to Spectrum Pharmaceuticals Inc in Q2 2020, an estimated $1.31M increase.
- Alethea Capital Management's biggest Q2 2020 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $17.1M.
- Alethea Capital Management fully exited Vivmark Residential in Q2 2020, selling an estimated $849K.
- Alethea Capital Management's ten largest holdings make up 80% of its $171M portfolio in Q2 2020.
- Alethea Capital Management opened 34 new positions and closed 26 in Q2 2020.
- Alethea Capital Management's portfolio value rose 11% quarter-over-quarter to $171M.
Based on Alethea Capital Management's 13F filing for Q2 2020, filed 11 Aug 2020.